CN110189014A - A kind of method and terminal of control performance that evaluating medical treatment cost - Google Patents
A kind of method and terminal of control performance that evaluating medical treatment cost Download PDFInfo
- Publication number
- CN110189014A CN110189014A CN201910438336.9A CN201910438336A CN110189014A CN 110189014 A CN110189014 A CN 110189014A CN 201910438336 A CN201910438336 A CN 201910438336A CN 110189014 A CN110189014 A CN 110189014A
- Authority
- CN
- China
- Prior art keywords
- cost
- disease
- medical treatment
- grouping
- control performance
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- G—PHYSICS
- G06—COMPUTING; CALCULATING OR COUNTING
- G06Q—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR ADMINISTRATIVE, COMMERCIAL, FINANCIAL, MANAGERIAL OR SUPERVISORY PURPOSES; SYSTEMS OR METHODS SPECIALLY ADAPTED FOR ADMINISTRATIVE, COMMERCIAL, FINANCIAL, MANAGERIAL OR SUPERVISORY PURPOSES, NOT OTHERWISE PROVIDED FOR
- G06Q10/00—Administration; Management
- G06Q10/06—Resources, workflows, human or project management; Enterprise or organisation planning; Enterprise or organisation modelling
- G06Q10/063—Operations research, analysis or management
- G06Q10/0639—Performance analysis of employees; Performance analysis of enterprise or organisation operations
- G06Q10/06393—Score-carding, benchmarking or key performance indicator [KPI] analysis
-
- G—PHYSICS
- G06—COMPUTING; CALCULATING OR COUNTING
- G06Q—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR ADMINISTRATIVE, COMMERCIAL, FINANCIAL, MANAGERIAL OR SUPERVISORY PURPOSES; SYSTEMS OR METHODS SPECIALLY ADAPTED FOR ADMINISTRATIVE, COMMERCIAL, FINANCIAL, MANAGERIAL OR SUPERVISORY PURPOSES, NOT OTHERWISE PROVIDED FOR
- G06Q50/00—Systems or methods specially adapted for specific business sectors, e.g. utilities or tourism
- G06Q50/10—Services
- G06Q50/22—Social work
Landscapes
- Business, Economics & Management (AREA)
- Human Resources & Organizations (AREA)
- Engineering & Computer Science (AREA)
- Tourism & Hospitality (AREA)
- Economics (AREA)
- Strategic Management (AREA)
- Development Economics (AREA)
- Educational Administration (AREA)
- Entrepreneurship & Innovation (AREA)
- Marketing (AREA)
- Physics & Mathematics (AREA)
- General Business, Economics & Management (AREA)
- General Physics & Mathematics (AREA)
- Health & Medical Sciences (AREA)
- Theoretical Computer Science (AREA)
- Child & Adolescent Psychology (AREA)
- General Health & Medical Sciences (AREA)
- Primary Health Care (AREA)
- Game Theory and Decision Science (AREA)
- Operations Research (AREA)
- Quality & Reliability (AREA)
- Medical Treatment And Welfare Office Work (AREA)
Abstract
The present invention provides the method and terminal of a kind of control performance for evaluating medical treatment cost, obtain the case data in preset time period, disease grouping and case carried out to case data using DRG group technology enter group to obtain to standard specimen sheet and commented sample, sample includes the medical treatment cost of each case of each disease grouping, according to the cost mean value for originally calculating separately each disease grouping to standard specimen, cost mean value computation population standard deviation corresponding with disease grouping and objective cost are grouped according to each disease, according to the sample standard deviation for being commented sample to calculate separately each disease grouping in default assessment period, the cost mean value being grouped according to each disease, objective cost, population standard deviation, sample standard deviation calculates the master control performance of the medical treatment cost in default assessment period, it is related to the control of each case medical treatment cost that it controls performance, it improves Evaluate the reasonability of the control performance of medical treatment cost.
Description
Technical field
The present invention relates to medical information technical field more particularly to it is a kind of evaluate medical treatment cost control performance method and
Terminal.
Background technique
Currently, hospital will also avoid curing in addition to focusing on the therapeutic effect of doctor with the continuous development of medical technology
It is wasted caused by giving birth to when using medical resource, therefore, the method for the control performance of most of hospital's in-service evaluation medical treatment costs
The control effect of the medical treatment cost of doctor is evaluated, and keeps medical treatment cost control effect and doctor personal according to evaluation score
Income hook, Lai Zengqiang doctor control the active consciousness and enthusiasm of medical treatment cost.
The method of the control performance of existing evaluation medical treatment cost is mainly key index method (KPI), and this method is that foundation is gone through
History data set an objective cost C to each department or each doctorT, according to this objective cost CTTo evaluate department or doctor
The control performance of raw medical treatment cost, this method have the disadvantage in that
Disadvantage one: with the increase of portfolio, the patient's number and amount for surgical that doctor accepts for medical treatment also increase, and medical treatment cost is also therewith
Increase, and objective cost CTSetting be but fixed and invariable, not accounting for medical treatment cost increase is the increase due to portfolio
Caused by, objective cost CTThe science of setting is poor, will affect the enthusiasm for labour of doctor instead.
Disadvantage two: original objective cost CTIt is to be released according to historical data, for the objective cost of each department, doctor
It is worth all different, ununified standard.There may be certain departments or doctor are natively more wasteful, hence for setting
Objective cost is easier to realize；Natively pay attention to saving very much there is also certain departments or doctor, hence for the target of setting
Cost is relatively difficult to achieve.
For the deficiency of key index method (KPI), more and more hospitals are come into effect based on DRG (Diagnosis
Related Group, DRG) method carries out performance appraisal to the control of the medical treatment cost of department, treatment and doctor, and DRG method is
A method of by diagnosis associated packets, it is the payment methods of current inpatient medical service widely used in the world, be by
Patient is divided into several groups according to the difference of disease severity, the complexity for the treatment of method and resource consumption, is single with group
Position unbundling, a kind of payment methods for being packaged payment.Implement the medical institutions of DRG grouping when case is left hospital, it will be comprising examining
Variable needed for disconnected, operation and DRG grouping is transferred to DRG burster.Each case is divided into unique DRG by DRG burster.
It, will also be close at cost or duration is close in hospital can just be divided into other than considering diagnosis, operation, the factors such as the state of an illness in grouping
Same group.Therefore, the case of same DRG, actual cost are closer to.But to department, treatment group and doctor based on DRG's
Performance appraisal directlys adopt the absolute value for the medical resource saved mostly to be examined, and such as A disease, sets cost control
Target is 6000 yuan, and actual cost is 5800 yuan, then obtains the reward of 200 integrals；B disease, setting Cost Control Target is 600
Member, actual cost are 580 yuan, then obtain the reward of 20 integrals.This is quite reasonable to the eye, actually implies unreasonable.
Because having saved 20 yuan for B disease, relatively entire cost has saved 3.33%, with A disease is identical from saving rate
's.That is, although B disease has only saved 20 yuan, as its effect worked hard with A disease is.If that is only
According to target cost savings rate is evaluated, and can be existed also problematic, it is assumed that and saving x% can get x points of reward, such as this example,
A disease and B disease often do an example, can get 3.33 points of reward.In general, costly disease number of cases can be fewer, such as
Fruit A disease one month 1, B disease 1 month 10, then 33.3 points of rewards is only obtained within A disease one month, can be obtained within B disease one month
333 points of reward, this seems unreasonable again.In addition, some diseases are saved very much, but it is difficult to reach objective cost；And have
Disease save space it is larger, be easy to reach objective cost, may exist waste.
It is thus impossible to rely solely on medical resource saving absolute value and saving rate to the control performance of valence medical treatment cost into
Row evaluation, and the control performance for how reasonably evaluating medical treatment cost becomes a urgent problem to be solved.
Summary of the invention
The technical problems to be solved by the present invention are: providing method and the end of a kind of control performance of evaluation medical treatment cost
End, can reasonably evaluate the control performance of medical treatment cost.
In order to solve the above-mentioned technical problem, a kind of technical solution that the present invention uses are as follows:
A method of the control performance of evaluation medical treatment cost, comprising:
Case data in S1, acquisition preset time period carry out disease point to the case data using DRG group technology
Group and case enter group and obtain to standard specimen sheet and commented sample, the sample include each case of each disease grouping medical treatment at
This；
S2, according to the cost mean value for originally calculating separately the grouping of each disease to standard specimen, according to each disease point
Group cost mean value computation population standard deviation corresponding with disease grouping and objective cost；
S3, sample is commented to calculate separately the sample standard deviation that each disease in default assessment period is grouped, root according to described
The medical treatment in default assessment period is calculated according to the cost mean value of each disease grouping, objective cost, population standard deviation, sample standard deviation
The master control performance of cost.
In order to solve the above-mentioned technical problem, the another technical solution that the present invention uses are as follows:
A kind of terminal of control performance that evaluating medical treatment cost, including memory, processor and store on a memory simultaneously
The computer program that can be run on a processor, the processor perform the steps of when executing the computer program
Case data in S1, acquisition preset time period carry out disease point to the case data using DRG group technology
Group and case enter group and obtain to standard specimen sheet and commented sample, the sample include each case of each disease grouping medical treatment at
This；
S2, according to the cost mean value for originally calculating separately the grouping of each disease to standard specimen, according to each disease point
Group cost mean value computation population standard deviation corresponding with disease grouping and objective cost；
S3, sample is commented to calculate separately the sample standard deviation that each disease in default assessment period is grouped, root according to described
The medical treatment in default assessment period is calculated according to the cost mean value of each disease grouping, objective cost, population standard deviation, sample standard deviation
The master control performance of cost.
The beneficial effects of the present invention are: the case data in preset time period are grouped by DRG group technology
It obtains to standard specimen sheet and is commented sample, described is population sample in preset time period to standard specimen sheet, and described to be commented sample be pre-
If the examination sample in assessment period, each disease is calculated according to the medical treatment cost of each case to each grouping in standard specimen sheet
The cost mean value of kind grouping goes out the population standard deviation and objective cost of each case grouping further according to the cost mean value computation, then
According to being commented sample to calculate the sample standard deviation in default assessment period, and then finally calculate the doctor in default assessment period
Treat the master control performance of cost；When carrying out control performance calculating, it is contemplated that cost mean value and standard deviation, and it is pre- calculating
If both considered when the master control performance of the medical treatment cost in assessment period in preset time period to standard specimen notebook data, it is also considered that it is default
Sample data is commented in assessment period, the reasonability of sample data is not only ensure that, has also unified evaluation criterion, ensure that medical treatment
The fairness of the control performance appraisal of cost, so as to improve the reasonability for the control performance for evaluating medical treatment cost, Jin Erneng
It enough motivates doctor to take seriously the control of the medical treatment cost of each case in diagnosis and treatment, reduces waste.
Detailed description of the invention
Fig. 1 is a kind of method flow diagram of the control performance of evaluation medical treatment cost of the embodiment of the present invention；
Fig. 2 is a kind of terminal structure schematic diagram of the control performance of evaluation medical treatment cost of the embodiment of the present invention；
Label declaration:
1, the terminal of the control performance of medical treatment cost is evaluated；2, memory；3, processor.
Specific embodiment
To explain the technical content, the achieved purpose and the effect of the present invention in detail, below in conjunction with embodiment and cooperate attached
Figure is explained.
Fig. 1 is please referred to, a method of the control performance of evaluation medical treatment cost, comprising:
Case data in S1, acquisition preset time period carry out disease point to the case data using DRG group technology
Group and case enter group and obtain to standard specimen sheet and commented sample, the sample include each case of each disease grouping medical treatment at
This；
S2, according to the cost mean value for originally calculating separately the grouping of each disease to standard specimen, according to each disease point
Group cost mean value computation population standard deviation corresponding with disease grouping and objective cost；
S3, sample is commented to calculate separately the sample standard deviation that each disease in default assessment period is grouped, root according to described
The medical treatment in default assessment period is calculated according to the cost mean value of each disease grouping, objective cost, population standard deviation, sample standard deviation
The master control performance of cost.
As can be seen from the above description, the beneficial effects of the present invention are: by DRG group technology to the disease in preset time period
Number of cases evidence is grouped to obtain to standard specimen sheet and is commented sample, and described is the population sample in preset time period, institute to standard specimen sheet
Stating and being commented sample is the examination sample in default assessment period, according to the medical treatment of each case to each grouping in standard specimen sheet at
Originally the cost mean value for calculating each disease grouping goes out the population standard deviation of each case grouping further according to the cost mean value computation
And objective cost, further according to being commented sample to calculate the sample standard deviation in default assessment period, and then finally calculate pre-
If the master control performance of the medical treatment cost in assessment period；When carrying out control performance calculating, it is contemplated that cost mean value and standard
Difference, and both considered when calculating the master control performance of the medical treatment cost in default assessment period in preset time period to standard specimen sheet
Data, it is also considered that commented sample data in default assessment period, not only ensure that the reasonability of sample data, also unified evaluation
Standard ensure that the fairness of the control performance appraisal of medical treatment cost, so as to improve the control performance of evaluation medical treatment cost
Reasonability, and then can motivate doctor taken seriously in diagnosis and treatment each case medical treatment cost control, reduce waste.
Further, originally calculating separately the cost mean value that each disease is grouped in the S2 to standard specimen according to described includes:
The medical treatment cost that each case of each disease grouping of sample acquisition is marked according to described pair, according to each disease
The medical treatment cost of each case of grouping calculates separately the cost mean value of each disease grouping, its calculation formula is:
In formula,Indicate the cost mean value of g group disease grouping,Indicate i-th of case of g group disease grouping
Medical treatment cost, n indicate the total cases of g group disease grouping.
Seen from the above description, the medical treatment cost for all cases being grouped by each disease calculates each disease grouping
The science of cost mean value, obtained cost mean value is high, using the cost mean value considering as the master control performance of medical treatment cost,
Further improve reasonability.
Further, corresponding with disease grouping according to each disease grouping cost mean value computation in the S2
Population standard deviation and objective cost include:
In formula, SgIndicate the population standard deviation of g group disease grouping,Indicate the cost mean value of g group disease grouping,Indicate the medical treatment cost of i-th of case of g group disease grouping, n indicates the total cases of g group disease grouping, CTIt indicates
The objective cost of g group disease grouping, AgIndicate cost adjusted value, the AgValue range be
Seen from the above description, each disease being grouped according to the cost mean value being grouped to each disease of standard specimen sheet and the disease
Population standard deviation is calculated in the medical treatment cost of example, scientific high, so as to intuitively find out the medical treatment of each disease grouping
The dispersion degree of cost；The objective cost and cost adjustment value that objective cost is grouped according to this group of disease are calculated, and this at
This adjusted value can change in the range intervals of setting according to the actual situation, to improve the flexibility of objective cost setting.
Further, according to the cost mean value of each disease grouping, objective cost, population standard deviation, sample in the S3
The master control performance that standard deviation calculates the medical treatment cost in default assessment period includes:
Default examine is calculated according to the cost mean value of each disease grouping, objective cost, population standard deviation and sample standard deviation
The control performance of the medical treatment cost of each case in the core phase is calculated according to the control performance of the medical treatment cost of each case
The master control performance of medical treatment cost in default assessment period；
The control performance calculation formula of the medical treatment cost of each case in the default assessment period are as follows:
In formula,Indicate the control performance of i-th of case of g group disease in default assessment period,It indicates default to examine
The medical treatment cost of g-th of disease, i-th of case, S in the core phasegIndicate the sample standard deviation of g group disease in default assessment period.
Seen from the above description, the control performance of the medical treatment cost of each case in the default assessment period is by each disease
The cost mean value of grouping, objective cost, population standard deviation, sample standard deviation calculating are got, scientific high, and to default assessment period
The control performance of the medical treatment cost of interior each case is calculated, and is improved comprehensive.
Further, the control performance of the medical treatment cost according to each case calculate the medical treatment in default assessment period at
The calculation formula of this master control performance are as follows:
In formula, ZdIndicate master control performance, n indicates that the total cases of g group disease, m indicate total group of number of disease.
Seen from the above description, the master control performance of the medical treatment cost in assessment period is preset by the medical treatment cost of each case
Control performance be calculated, guarantee sample calculate it is comprehensive, obtained from preset assessment period in medical treatment cost it is total
It is good to control performance reasonability, accuracy is high.
Referring to figure 2., a kind of terminal of control performance that evaluating medical treatment cost, including memory, processor and be stored in
On memory and the computer program that can run on a processor, the processor are realized following when executing the computer program
Step:
Case data in S1, acquisition preset time period carry out disease point to the case data using DRG group technology
Group and case enter group and obtain to standard specimen sheet and commented sample, the sample include each case of each disease grouping medical treatment at
This；
S2, according to the cost mean value for originally calculating separately the grouping of each disease to standard specimen, according to each disease point
Group cost mean value computation population standard deviation corresponding with disease grouping and objective cost；
S3, sample is commented to calculate separately the sample standard deviation that each disease in default assessment period is grouped, root according to described
The medical treatment in default assessment period is calculated according to the cost mean value of each disease grouping, objective cost, population standard deviation, sample standard deviation
The master control performance of cost.
As can be seen from the above description, the beneficial effects of the present invention are: by DRG group technology to the disease in preset time period
Number of cases evidence is grouped to obtain to standard specimen sheet and is commented sample, and described is the population sample in preset time period, institute to standard specimen sheet
Stating and being commented sample is the examination sample in default assessment period, according to the medical treatment of each case to each grouping in standard specimen sheet at
Originally the cost mean value for calculating each disease grouping goes out the population standard deviation of each case grouping further according to the cost mean value computation
And objective cost, further according to being commented sample to calculate the sample standard deviation in default assessment period, and then finally calculate pre-
If the master control performance of the medical treatment cost in assessment period；When carrying out control performance calculating, it is contemplated that cost mean value and standard
Difference, and both considered when calculating the master control performance of the medical treatment cost in default assessment period in preset time period to standard specimen sheet
Data, it is also considered that commented sample data in default assessment period, not only ensure that the reasonability of sample data, also unified evaluation
Standard ensure that the fairness of the control performance appraisal of medical treatment cost, so as to improve the control performance of evaluation medical treatment cost
Reasonability, and then can motivate doctor taken seriously in diagnosis and treatment each case medical treatment cost control, reduce waste.
Further, originally calculating separately the cost mean value that each disease is grouped in the S2 to standard specimen according to described includes:
The medical treatment cost that each case of each disease grouping of sample acquisition is marked according to described pair, according to each disease
The medical treatment cost of each case of grouping calculates separately the cost mean value of each disease grouping, its calculation formula is:
In formula,Indicate the cost mean value of g group disease grouping,Indicate i-th of case of g group disease grouping
Medical treatment cost, n indicate the total cases of g group disease grouping.
Seen from the above description, the medical treatment cost for all cases being grouped by each disease calculates each disease grouping
The science of cost mean value, obtained cost mean value is high, using the cost mean value considering as the master control performance of medical treatment cost,
Further improve reasonability.
Further, corresponding with disease grouping according to each disease grouping cost mean value computation in the S2
Population standard deviation and objective cost include:
In formula, SgIndicate the population standard deviation of g group disease grouping,Indicate the cost mean value of g group disease grouping,Indicate the medical treatment cost of i-th of case of g group disease grouping, n indicates the total cases of g group disease grouping, CTIt indicates
The objective cost of g group disease grouping, AgIndicate cost adjusted value, the AgValue range be
Seen from the above description, each disease being grouped according to the cost mean value being grouped to each disease of standard specimen sheet and the disease
Population standard deviation is calculated in the medical treatment cost of example, scientific high, so as to intuitively find out the medical treatment of each disease grouping
The dispersion degree of cost；The objective cost and cost adjustment value that objective cost is grouped according to this group of disease are calculated, and this at
This adjusted value can change in the range intervals of setting according to the actual situation, to improve the flexibility of objective cost setting.
Further, according to the cost mean value of each disease grouping, objective cost, population standard deviation, sample in the S3
The master control performance that standard deviation calculates the medical treatment cost in default assessment period includes:
Default examine is calculated according to the cost mean value of each disease grouping, objective cost, population standard deviation and sample standard deviation
The control performance of the medical treatment cost of each case in the core phase is calculated according to the control performance of the medical treatment cost of each case
The master control performance of medical treatment cost in default assessment period；
The control performance calculation formula of the medical treatment cost of each case in the default assessment period are as follows:
In formula,Indicate the control performance of i-th of case of g group disease in default assessment period,It indicates default to examine
The medical treatment cost of g-th of disease, i-th of case, S' in the core phasegIndicate the sample standard deviation of g group disease in default assessment period.
Seen from the above description, the control performance of the medical treatment cost of each case in the default assessment period is by each disease
The cost mean value of grouping, objective cost, population standard deviation, sample standard deviation calculating are got, scientific high, and to default assessment period
The control performance of the medical treatment cost of interior each case is calculated, and is improved comprehensive.
Further, the control performance of the medical treatment cost according to each case calculate the medical treatment in default assessment period at
The calculation formula of this master control performance are as follows:
In formula, ZdIndicate master control performance, n indicates that the total cases of g group disease, m indicate total group of number of disease.
Seen from the above description, the master control performance of the medical treatment cost in assessment period is preset by the medical treatment cost of each case
Control performance be calculated, guarantee sample calculate it is comprehensive, obtained from preset assessment period in medical treatment cost it is total
It is good to control performance reasonability, accuracy is high.
Embodiment one
Fig. 1 is please referred to, a method of the control performance of evaluation medical treatment cost, comprising:
Case data in S1, acquisition preset time period carry out disease point to the case data using DRG group technology
Group and case enter group and obtain to standard specimen sheet and commented sample, the sample include each case of each disease grouping medical treatment at
This；
Wherein, DRG cost determines target data from the sample survey according to evaluation demand, mainly chooses from three dimensions:
1, time dimension: if with the historical cost of our unit to mark, data from the sample survey be derived from previous year or it is bigger when
Between span.
2, Spatial Dimension: if with a certain hospital to mark, data from the sample survey is derived from a certain hospital；If with area or the whole nation
To mark, then data from the sample survey is derived from area or the whole nation.
3, rank dimension: if in hospital to mark with same type or elder generation, data from the sample survey is derived from same type or first in hospital.
S2, according to the cost mean value for originally calculating separately the grouping of each disease to standard specimen, according to each disease point
Group cost mean value computation population standard deviation corresponding with disease grouping and objective cost；
Specifically, what the population standard deviation calculated is that each disease grouping is corresponding in case data in preset time period
Cost standard is poor；
Wherein, originally calculating separately the cost mean value that each disease is grouped to standard specimen according to described includes:
The medical treatment cost that each case of each disease grouping of sample acquisition is marked according to described pair, according to each disease
The medical treatment cost of each case of grouping calculates separately the cost mean value of each disease grouping, its calculation formula is:
In formula,Indicate the cost mean value of g group disease grouping,Indicate i-th of case of g group disease grouping
Medical treatment cost, n indicate the total cases of g group disease grouping；
Wherein, according to each disease grouping cost mean value computation population standard deviation corresponding with disease grouping and
Objective cost includes:
In formula, SgIndicate the population standard deviation of g group disease grouping,Indicate the cost mean value of g group disease grouping,Indicate the medical treatment cost of i-th of case of g group disease grouping, n indicates the total cases of g group disease grouping；
CTIndicate the objective cost of g group disease grouping, AgIndicate cost adjusted value, the AgValue range be
In addition, the CTValue there are two types of scheme it is available:
The first, in the area that implementation DRG method is paid, medical insurance office can provide the payment standards of each disease.Hospital
It can disease objective cost C according to this payment standards as hospitalT。
It is second, described in the case where only hospital carries out the also unexecuted DRG payment in DRG payment areaValue
The cost mean value for referring to the g group disease grouping to standard specimen sheet, then according to above-mentioned formula CT=Cg+AgDetermine g group disease
The objective cost of grouping.
S3, sample is commented to calculate separately the sample standard deviation that each disease in default assessment period is grouped, root according to described
The medical treatment in default assessment period is calculated according to the cost mean value of each disease grouping, objective cost, population standard deviation, sample standard deviation
The master control performance of cost；
Specifically, the sample standard deviation calculating is each disease in the case data for being commented sample preset in assessment period
The corresponding cost standard of kind grouping is poor, and the time span of default assessment period is generally no greater than the time span of preset time period.Than
If preset time period was set as the past in 1 year, default assessment period was set as the past in one month, then population standard deviation calculates
It is that the cost standard that each disease is grouped in the case data in past 1 year is poor, then what sample standard deviation calculated is one in the past
The cost standard of each disease grouping is poor in case data in month.The calculation formula of the sample standard deviation and population standard deviation phase
Together, difference is that the period for acquiring case data is different.By taking default assessment period was set as the past in one month as an example, then first according to
According to DRG method to the case data in past one month carry out disease grouping and case enter group obtain it is corresponding commented sample, into
And calculate over the sample standard deviation in one month.
Wherein, it is calculated according to the cost mean value of each disease grouping, objective cost, population standard deviation, sample standard deviation pre-
If the master control performance of the medical treatment cost in assessment period includes:
According to the cost mean value of each disease grouping, objective cost, population standard deviation, sample standard deviation and calculate default examine
The control performance of the medical treatment cost of each case in the core phase is calculated according to the control performance of the medical treatment cost of each case
The master control performance of medical treatment cost in default assessment period；
The control performance calculation formula of the medical treatment cost of each case are as follows:
In formula,Indicate the control performance of i-th of case of default assessment period g group disease,Indicate default examination
The medical treatment cost of g-th of phase, i-th of disease case, S'gIndicate the sample standard deviation of the disease of default assessment period, SgIt is to be commented sample
This population standard deviation.Work as SgWhen being difficult to seek, S can be takeng=S'g。
Wherein, the medical treatment cost in default assessment period is calculated according to the control performance of the medical treatment cost of each case
The calculation formula of master control performance are as follows:
In formula, ZdIndicate master control performance, n indicates that the total cases of g group disease, m indicate total group of number of disease.
In practical application scene, most of hospitals in China are carried out from hospital to department, department to personal second level achievement
Effect examination and bonus secondary distribution system, by taking department d as an example, above-mentioned calculation formula can be used for calculating department d in default examination
The master control performance of medical treatment cost in phase, then Z in above-mentioned formuladIndicate the total of medical treatment cost of the department d in default assessment period
Control performance.If total medical treatment cost of department d is lower than general objective cost in assessment period, master control performance is positive, is expressed as
This control obtains effect；Conversely, master control performance is negative, indicate that cost control is unfavorable.Once a certain case grouping in assessment period
Medical treatment cost be higher than objective cost, then master control performance is negative, and needs the medical treatment cost of other case saving to make up, otherwise
The master control performance of this month is negative, department and the personal reward that will be unable to obtain this respect.
Therefore, the master control performance of this programme is related to the quantity of case, but does not represent that case is more, master control performance
Score value is higher.Score value height, the effort from each case cost control can motivate doctor in diagnosis and treatment, can recognize in this way
The cost control for really treating each case prevents the big prescription of thorough examination and over-treatment.
Embodiment two
Referring to figure 2., a kind of terminal 1 of control performance that evaluating medical treatment cost, including memory 2, processor 3 and storage
On memory 2 and the computer program that can run on processor 3, the processor 3 execute real when the computer program
Step in current embodiment one.
In conclusion the method and terminal of a kind of control performance for evaluating medical treatment cost provided by the invention, pass through DRG points
Group device carries out disease grouping and case to case data and enters group obtaining to standard specimen sheet and commented sample, and calculates each disease with this
The cost mean value of grouping, according to cost mean value computation population standard deviation and objective cost, and it is pre- according to being commented sample to calculate separately
If the sample standard deviation that each disease in assessment period is grouped, finally calculates the master control of the medical treatment cost in default assessment period
Performance.When carrying out control performance calculating, it is contemplated that cost mean value and standard deviation, and calculating the doctor in default assessment period
Both considered when treating the master control performance of cost in preset time period to standard specimen notebook data, it is also considered that being commented in default assessment period
Sample data not only ensure that the reasonability of sample data, also unify evaluation criterion, ensure that the control performance of medical treatment cost
The fairness of evaluation so as to improve the reasonability for the control performance for evaluating medical treatment cost, and then can motivate doctor examining
The control that the medical treatment cost of each case is taken seriously when controlling reduces waste.
The above description is only an embodiment of the present invention, is not intended to limit the scope of the invention, all to utilize this hair
Equivalents made by bright specification and accompanying drawing content are applied directly or indirectly in relevant technical field, similarly include
In scope of patent protection of the invention.
Claims (10)
1. a kind of method for the control performance for evaluating medical treatment cost characterized by comprising
S1, obtain preset time period in case data, using DRG group technology to the case data carry out disease grouping and
Case enters group and obtains to standard specimen sheet and commented sample, and the sample includes the medical treatment cost of each case of each disease grouping；
S2, according to the cost mean value for originally calculating separately the grouping of each disease to standard specimen, be grouped as according to each disease
This mean value computation population standard deviation corresponding with disease grouping and objective cost；
S3, sample is commented to calculate separately the sample standard deviation that each disease in default assessment period is grouped according to described, according to each
Cost mean value, objective cost, population standard deviation, the sample standard deviation of a disease grouping calculate the medical treatment cost in default assessment period
Master control performance.
2. the method for the control performance of evaluation medical treatment cost according to claim 1, which is characterized in that basis in the S2
The cost mean value that the grouping of each disease is originally calculated separately to standard specimen includes:
The medical treatment cost that each case of each disease grouping of sample acquisition is marked according to described pair, is grouped according to each disease
The medical treatment cost of each case calculate separately the cost mean value of each disease grouping, its calculation formula is:
In formula,Indicate the cost mean value of g group disease grouping,Indicate the medical treatment of i-th of case of g group disease grouping
Cost, n indicate the total cases of g group disease grouping.
3. the method for the control performance of evaluation medical treatment cost according to claim 1, which is characterized in that basis in the S2
Each disease is grouped cost mean value computation population standard deviation corresponding with disease grouping and objective cost includes:
In formula, SgIndicate the population standard deviation of g group disease grouping,Indicate the cost mean value of g group disease grouping,Table
Show the medical treatment cost of i-th of case of g group disease grouping, n indicates the total cases of g group disease grouping, CTIndicate g group
The objective cost of disease grouping, AgIndicate cost adjusted value, the AgValue range be
4. the method for the control performance of evaluation medical treatment cost according to claim 1, which is characterized in that basis in the S3
Cost mean value, objective cost, population standard deviation, the sample standard deviation of each disease grouping calculate the medical treatment in default assessment period at
This master control performance includes:
Default assessment period is calculated according to the cost mean value of each disease grouping, objective cost, population standard deviation and sample standard deviation
The control performance of the medical treatment cost of interior each case calculates default according to the control performance of the medical treatment cost of each case
The master control performance of medical treatment cost in assessment period；
The control performance calculation formula of the medical treatment cost of each case in the default assessment period are as follows:
In formula,Indicate the control performance of i-th of case of g group disease in default assessment period,Indicate default assessment period
The medical treatment cost of interior g-th of disease, i-th of case, S'gIndicate the sample standard deviation of g group disease in default assessment period.
5. the method for the control performance of evaluation medical treatment cost according to claim 4, which is characterized in that the basis is each
The control performance of the medical treatment cost of case calculates the calculation formula of the master control performance of the medical treatment cost in default assessment period are as follows:
In formula, ZdIndicate master control performance, n indicates that the total cases of g group disease, m indicate total group of number of disease.
6. a kind of terminal for the control performance for evaluating medical treatment cost, including memory, processor and store on a memory and can
The computer program run on a processor, which is characterized in that the processor is realized following when executing the computer program
Step:
S1, obtain preset time period in case data, using DRG group technology to the case data carry out disease grouping and
Case enters group and obtains to standard specimen sheet, and described originally includes the medical treatment cost of each case of each disease grouping to standard specimen；
S2, according to the cost mean value for originally calculating separately the grouping of each disease to standard specimen, be grouped as according to each disease
This mean value computation population standard deviation corresponding with disease grouping and objective cost；
S3, sample is commented to calculate separately the sample standard deviation that each disease in default assessment period is grouped according to described, according to each
Each disease in cost mean value, objective cost, population standard deviation, sample standard deviation and the default assessment period that a disease is grouped
The master control performance that the medical treatment cost in assessment period is preset to this calculating of standard specimen of grouping.
7. the terminal of the control performance of evaluation medical treatment cost according to claim 6, which is characterized in that basis in the S2
The cost mean value that the grouping of each disease is originally calculated separately to standard specimen includes:
The medical treatment cost that each case of each disease grouping of sample acquisition is marked according to described pair, is grouped according to each disease
The medical treatment cost of each case calculate separately the cost mean value of each disease grouping, its calculation formula is:
In formula,Indicate the cost mean value of g group disease grouping,Indicate the medical treatment of i-th of case of g group disease grouping
Cost, n indicate the total cases of g group disease grouping.
8. the terminal of the control performance of evaluation medical treatment cost according to claim 6, which is characterized in that basis in the S2
Each disease is grouped cost mean value computation population standard deviation corresponding with disease grouping and objective cost includes:
In formula, SgIndicate the population standard deviation of g group disease grouping,Indicate the cost mean value of g group disease grouping,Table
Show the medical treatment cost of i-th of case of g group disease grouping, n indicates the total cases of g group disease grouping, CTIndicate g group
The objective cost of disease grouping, AgIndicate cost adjusted value, the AgValue range be
9. the terminal of the control performance of evaluation medical treatment cost according to claim 1, which is characterized in that basis in the S3
Cost mean value, objective cost, population standard deviation, the sample standard deviation of each disease grouping calculate the medical treatment in default assessment period at
This master control performance includes:
Default assessment period is calculated according to the cost mean value of each disease grouping, objective cost, population standard deviation and sample standard deviation
The control performance of the medical treatment cost of interior each case calculates default according to the control performance of the medical treatment cost of each case
The master control performance of medical treatment cost in assessment period；
The control performance calculation formula of the medical treatment cost of each case in the default assessment period are as follows:
In formula,Indicate the control performance of i-th of case of g group disease in default assessment period,Indicate default assessment period
The medical treatment cost of interior g-th of disease, i-th of case, S'gIndicate the sample standard deviation of g group disease in default assessment period.
10. the terminal of the control performance of evaluation medical treatment cost according to claim 9, which is characterized in that according to described every
The control performance of the medical treatment cost of a case calculates the calculation formula of the master control performance of the medical treatment cost in default assessment period are as follows:
In formula, ZdIndicate master control performance, n indicates that the total cases of g group disease, m indicate total group of number of disease.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201910438336.9A CN110189014A (en) | 2019-05-24 | 2019-05-24 | A kind of method and terminal of control performance that evaluating medical treatment cost |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201910438336.9A CN110189014A (en) | 2019-05-24 | 2019-05-24 | A kind of method and terminal of control performance that evaluating medical treatment cost |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN110189014A true CN110189014A (en) | 2019-08-30 |
Family
ID=67717634
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201910438336.9A Pending CN110189014A (en) | 2019-05-24 | 2019-05-24 | A kind of method and terminal of control performance that evaluating medical treatment cost |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN110189014A (en) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN111325576A (en) * | 2020-02-17 | 2020-06-23 | 卫宁健康科技集团股份有限公司 | Method and system for predicting cost of disease diagnosis related group and electronic equipment |
| CN112686683A (en) * | 2020-12-08 | 2021-04-20 | 望海康信(北京)科技股份公司 | Cost accounting system, and corresponding apparatus and storage medium |
-
2019
- 2019-05-24 CN CN201910438336.9A patent/CN110189014A/en active Pending
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN111325576A (en) * | 2020-02-17 | 2020-06-23 | 卫宁健康科技集团股份有限公司 | Method and system for predicting cost of disease diagnosis related group and electronic equipment |
| CN112686683A (en) * | 2020-12-08 | 2021-04-20 | 望海康信(北京)科技股份公司 | Cost accounting system, and corresponding apparatus and storage medium |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Liu et al. | The cost escalation of social health insurance plans in China: its implication for public policy | |
| Bhat | Institutional arrangements and efficiency of health care delivery systems | |
| Acemoglu et al. | Young, restless and creative: Openness to disruption and creative innovations | |
| Shapiro et al. | Containing costs while improving quality of care: the role of profiling and practice guidelines | |
| Morgan et al. | Characteristics of primary care office visits to nurse practitioners, physician assistants and physicians in United States Veterans Health Administration facilities, 2005 to 2010: a retrospective cross-sectional analysis | |
| Liu et al. | Financing reforms of public health services in China: lessons for other nations | |
| Castillo et al. | Sleepiness, choice consistency, and risk preferences | |
| Van Houdenhoven et al. | A norm utilisation for scarce hospital resources: evidence from operating rooms in a Dutch university hospital | |
| CN110189014A (en) | A kind of method and terminal of control performance that evaluating medical treatment cost | |
| CN108053118A (en) | Doctor's scheduling method and system | |
| CN109934439A (en) | A kind of method of Allocation of Medical Resources, system and terminal device | |
| Li et al. | The impacts of marketization and subsidies on the treatment quality performance of the Chinese hospitals sector | |
| CN102197992A (en) | Method, device and computer program product for determining an indicator of generator clinical state | |
| CN110265153A (en) | Chronic disease follow-up method and electronic device | |
| Propper et al. | The use of performance measures in health care systems | |
| De Luca et al. | Value-at-Risk dynamics: a copula-VAR approach | |
| Xinxiang et al. | A comparison study of outpatient visits forecasting effect between ARIMA with seasonal index and SARIMA | |
| Di Matteo | Policy choice or economic fundamentals: what drives the public–private health expenditure balance in Canada? | |
| CN116316635A (en) | Electric power cooperative control method and system based on measurement information | |
| Xu et al. | An artificial urban healthcare system and applications | |
| An et al. | Pay-for-performance incentives in benchmarking with quasi S-shaped technology | |
| CN114201369A (en) | Server cluster management method and device, electronic equipment and storage medium | |
| CN111324864B (en) | Power demand response implementation cost and compensation standard evaluation method | |
| CN113706111A (en) | Method, device, equipment and medium for processing medical institution process data | |
| Gazioğlu et al. | Cumulative prospect theory challenges traditional expected utility theory |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20190830 |